In the United States, the demand for functional beverages has surged, leading to a significant increase in the consumption of fruit flower tea. However, the US market faces a critical gap in pharmaceutical-grade processing facilities capable of handling delicate botanical materials while maintaining bio-activity.
The climatic diversity of North America means that imported herbal pieces must undergo rigorous stabilization processes to avoid degradation during long-haul logistics. This has created a high barrier to entry for exporters who cannot guarantee the purity and pesticide-free status of mum tea.
Current market trends indicate a shift toward "Clean Label" products. US consumers are no longer satisfied with generic imports; they require transparent traceability and pharmaceutical-grade processing that eliminates contaminants while preserving the therapeutic properties of the flower.